Sarah Faghihi Research Compliance Decision Support Analyst Office of Research Administration Faith Pottschmidt, JD Director, Clinical Trials Contracting,

Slides:



Advertisements
Similar presentations
Chiari Surgical Outcomes Trial PI: Bermans J. Iskandar and Timothy George with collaboration from John Kestle ASAP-funded pilot study ASAP-funded pilot.
Advertisements

Tips to a Successful Monitoring Visit
USC Clinical Trials Office (CTO) Answers to CTOs who, what, when, and how questions Soheil Jadali Director, Clinical Trial Office.
David Cloutier Director, Research Center Management and Development Budgeting for Industry Sponsored Clinical Trials.
Submission to Approval What happens to my protocol once I submit it to the HIC office.
Line Efficiency     Percentage Month Today’s Date
Columbia University IRB IRB 101 September 21, 2005 George Gasparis, Executive Director, CU IRB Asst. V.P. and Sr. Asst. Dean for Research Ethics.
November 10, Office of Research Administration: Clinical Research Contracting Presented to: Research Administration Professionals Group Patricia.
1 Office of Research Administration Clinical Research Support Services 1629 S. Thames Street, Suite 200 Baltimore, Maryland /office /fax.
Unlocking the Mystery of General Information Reporting Research Compliance Administration Training Presentation Wednesday, June 6, 2007 Presenter:Heather.
The Contracting Process (Why Does it Take So Long?) Libby Salberg, Associate Director Beth Watkins, Contract Analyst, Team Manager Janet Fry, Manager Clinical.
Using Technology to Strengthen Human Subject Protections Patricia Scannell Director, IRB Washington University School of Medicine.
Michelle Groy Johnson Quality Improvement Officer Research Integrity Office Tough Love: Understanding the Purpose and Processes of Quality Assurance.
Budget Development Presented by: Jean Mercer Associate Director for Clinical Research Administration Office of Clinical Research – School of Medicine.
Tips on Routing and Contracts: An Intro for the Campus Research Coordinator Michelle Artmeier Director of Award Services Ron.
Office of Research & Sponsored Programs (ORSP) Darren McCants, Director David Azbill, Assistant Director Cindy Brown, Program Mgr, Corporate Research Robbie.
LETTER OF INTENT FOR INDUSTRY SPONSORED RESEARCH Signe Denmark, SCTR Research Opportunities & Collaborations Ryan Mulligan, SCTR Grants & Contracts Navigator.
University of Minnesota Internal\External Sales “The Internal Sales Review Process” An Overview of What Happens During the Review.
Human Subjects Research Office of Responsible Research Practices Human Subjects Research Vanessa Hill, MSHS, CCRC Senior Quality Improvement Specialist.
Business Operations Pre-Award. What is required to begin the business process? Possible indicators CDA executed Cancer Center MDG/PRC approvals Department.
Office for Research Subjects (ORS) & Research Administration (ORA) In-Sync to Help Make your Research Happen Stephanie Gaudreau, Sr.Research Subjects Specialist,
ProjectImpactResourcesDeadlineResourcesDeadline Forecast Plan Time Resources Risk 001xx 002xx 003xx 004xx 005xx 006xx 007xx TotalXX Example 1: Portfolio.
Korea Food & Drug Administration Deputy director Kwang-Soo Joo Korea FDA Sep. 29, 2000 : Korean Good Clinical Practice & Relative Guidelines How to Manage.
May 5, 2016 Working With CTO Contracting: How Do I Get My Clinical Trial Contract Negotiated & Why Isn’t It Signed Yet? Jaci Brown, Manager, CTO-Contracting.
Business Operations Pre-Award. Confidential Disclosure Agreements (CDA)/ Non-Disclosure Agreements (NDA)
© 2016 University at Buffalo Click Training IRB Module University at Buffalo Office of the Vice President for Research and Economic Development Electronic.
Making Clinical Trials More Efficient Site Management Organization (SMO)
Reinventing the Award Review and Set-Up Process NCURA Annual Meeting November 2012 Marcia Smith, Associate Vice Chancellor, Research Administration, UCLA.
HRPP METRICS Cynthia Monahan, MBA, CIP IRB Director Boston University Charles River Campus IRB.
Overview of Structure General Data Protection Regulation (GDPR)
Jan 2016 Solar Lunar Data.
Undergraduate Admissions Replacement Kickoff
Timeline Roadmap Template
Introduction to Sponsored Programs

IRB Compliance Program PRS Administrator, Brian Brotzman
Terri Tommasone & Diana Abinader
Introduction to Sponsored Programs
<Location> – <Project Name>, Sponsor: <name>
Claire McKinley, PMP, CCRP

Clinical Trials Budgeting, Part 2


Self-Insurance Application Schedule – Key Dates*


Q1 Q2 Q3 Q4 PRODUCT ROADMAP TITLE Roadmap Tagline MILESTONE MILESTONE



Wireless Local Number Portability Timeline - Phase 2
MAINTAINING THE INVESTIGATOR’S STUDY FILE
IRB Compliance Program PRS Administrator, Brian Brotzman

Oct 16th, 2018 January 2019.


XRN Nov 19 Release - Status Update
XRN Nov 19 Release - Status Update


Q1 Q2 Q3 Q4 PRODUCT ROADMAP TITLE Roadmap Tagline MILESTONE MILESTONE


TIMELINE NAME OF PROJECT Today 2016 Jan Feb Mar Apr May Jun
Wireless Local Number Portability Timeline - Phase 2

Q1 Q2 Q3 Q4 PRODUCT ROADMAP TITLE Roadmap Tagline MILESTONE MILESTONE
Pilot of revised survey
Presentation transcript:

Sarah Faghihi Research Compliance Decision Support Analyst Office of Research Administration Faith Pottschmidt, JD Director, Clinical Trials Contracting, CTSI

Identify Customer Needs o Timely Negotiations o Reduce Legal Risks o Ensure Compliance – Federal, State and local regulations; University policies Design for Efficiency, Accuracy and Reality o Shift priority of the workload o Clinical Need/Condition/Subject Population o Study phase and protocol procedures impact on contract terms o Type of contract submission (HUD or Work Order) o Align personnel skills to the specific tasks (negotiating contracts vs. account setup and maintenance) o Consider cradle to grave processes (amendments)

 Workflow Illustration for training purposes – both internal and external uses.  SharePoint for data capture, management of daily workload, logging activity, sharing information within office, and evaluating staff performance.  Work Files setup consistently for maintaining electronic versions.  Forms for Takeout that track the many checkbox functions are completed in the correct order.

9 MonthAmendsCDA'sCTAsMisc In Progress Jul Aug Sep Oct Nov Dec Jan Feb Mar Volumes of Documents at the CTC

 Data capture made it possible for ORA to perform a snapshot analysis of industry sponsored clinical trials ◦ Goal: illustrate the length of time between CDA submission and first consented subject ◦ Data Source: SharePoint query for contracts activated during Fiscal Year 2010 (Jul 09 – Jun 10) that had corresponding CDA’s ◦ Design: Chose 3 studies based on contractual relationship  Sponsor – Institution  Sponsor – Institution Under Master  Sponsor – CRO – Institution

Phase 2 – CRO; no Work Order Maximum Subject Enrollment per Contract: 30 Potential of Full Value of Contract: $308,213 Date of First Consent: 5/25/2010 Actual Consented Subjects as of Nov 2010: 11

Study A: ORA Contract Timeline Detail Based on CTSA Milestones Days: Median Turnaround Reported for Fiscal Year 2010 New Clinical Trial Contracts Calendar Days Days from Negotiation Start to Study Activation 03/05/1005/04/10 Days from Negotiation Start to First Comments Provided to Sponsor Days from First Comments Provided to Sponsor to Negotiation Complete Days from Negotiation Complete to Institution Execution Days from Institution Execution to Full Execution Days from Full Execution to Study Activation Total Date Negotiations Started Date First Comments Provided to Sponsor Date Negotiations Completed Date of Institution Execution Date of Full Execution Date of Study Activation [ Intake and Negotiation Phase ][ Signature and Activation Phase ]

Study A: ORA IRB Timeline Detail Based on CTSA Milestones Date Application Received Date Pre- Review Change Requests Sent to PI Date PI Resubmits Pre-Review Changes Date of First Full IRB Review Date Post- Review Change Requests Sent to PI Date PI Resubmits Post-Review Changes Date of Final IRB Approval Days: Median Turnaround Reported for Fiscal Year 2010 New Full Board Approvals Calendar Days Days from Application Received to Final IRB Approval Days from Application Received to Pre-Review Change Requests Sent to PI Days from Pre-Review Change Requests Sent to PI to PI Resubmits Pre-Review Changes Days from PI Resubmits Pre-Review Changes to First Full IRB Review Days from First Full IRB Review to Post-Review Change Requests Sent to PI Days from Post-Review Change Requests Sent to PI to PI Resubmits Post-Review Changes Days from PI Resubmits Post-Review Changes to Final IRB Approval LEGEND ORA PI 03/23/1004/22/10 Total [ Pre-Review Phase ][ Post-Review Phase ]

Phase 1 – Work Order; no CRO Maximum Subject Enrollment per Contract: 7 Potential of Full Value of Contract: $117,078 Date of First Consent: 5/18/2010 Actual Consented Subjects as of Nov 2010: 5

26 Days from Institution Execution to Full Execution Days from Negotiation Complete to Institution Execution Days from First Comments Provided to Negotiation Complete Days from Negotiation Start to First Comments Provided Days from Full Execution to Study Activation Total 37 Days: Median Turnaround Reported for Fiscal Year 2010 New Clinical Trial Contracts Study B: ORA Contract Timeline Detail Based on CTSA Milestones Calendar Days Days from Negotiation Start to Study Activation 04/06/1003/11/10 Date Negotiations Started Date First Comments Provided to Sponsor Date Negotiations Completed Date of Institution Execution Date of Full Execution Date of Study Activation [ Intake and Negotiation Phase ][ Signature and Activation Phase ]

Total 2 58 Days: Median Turnaround Reported for Fiscal Year 2010 New Full Board Approvals Study B: ORA IRB Timeline Detail Based on CTSA Milestones Days from Application Received to Final IRB Approval Days from Application Received to Pre-Review Change Requests Sent to PI Days from Pre-Review Change Requests Sent to PI to PI Resubmits Pre-Review Changes Days from PI Resubmits Pre-Review Changes to First Full IRB Review Days from First Full IRB Review to Post-Review Change Requests Sent to PI Days from Post-Review Change Requests Sent to PI to PI Resubmits Post-Review Changes Days from PI Resubmits Post-Review Changes to Final IRB Approval Calendar Days 01/29/1003/03/10 Date Application Received Date Pre- Review Change Requests Sent to PI Date PI Resubmits Pre-Review Changes Date of First Full IRB Review Date Post- Review Change Requests Sent to PI Date PI Resubmits Post-Review Changes Date of Final IRB Approval [ Pre-Review Phase ][ Post-Review Phase ] LEGEND ORA PI

Phase 1/2 – No Work Order or CRO Maximum Subject Enrollment per Contract: 20 Potential of Full Value of Contract: $78,285 Date of First Consent: 5/27/2010 Actual Consented Subjects as of Nov 2010: 6

/16/10 37 Days: Median Turnaround Reported for Fiscal Year 2010 New Clinical Trial Contracts Study C: ORA Contract Timeline Detail Based on CTSA Milestones Date from Negotiation Start to Date First Comments Provided to Sponsor Date First Comments Provided to Sponsor to Date Negotiation Complete Date Negotiation Complete to Date of Institution Execution Date of Institution Execution to Date of Full Execution Date of Full Execution to Date of Study Activation 05/18/10 Date from Negotiation Start to Date of Study Activation Calendar Days 63 Total Date Negotiations Started Date First Comments Provided to Sponsor Date Negotiations Completed Date of Institution Execution Date of Full Execution Date of Study Activation [ Intake and Negotiation Phase ][ Signature and Activation Phase ]

Total Days: Median Turnaround Reported for Fiscal Year 2010 New Full Board Approvals Study C: ORA IRB Timeline Detail Based on CTSA Milestones Days from Application Received to Final IRB Approval Days from Application Received to Pre-Review Change Requests Sent to PI Days from Pre-Review Change Requests Sent to PI to PI Resubmits Pre-Review Changes Days from PI Resubmits Pre-Review Changes to First Full IRB Review Days from First Full IRB Review to Post-Review Change Requests Sent to PI Days from Post-Review Change Requests Sent to PI to PI Resubmits Post-Review Changes Days from PI Resubmits Post-Review Changes to Final IRB Approval Calendar Days 03/02/1004/27/10 Date Application Received Date Pre- Review Change Requests Sent to PI Date PI Resubmits Pre-Review Changes Date of First Full IRB Review Date Post- Review Change Requests Sent to PI Date PI Resubmits Post-Review Changes Date of Final IRB Approval [ Pre-Review Phase ][ Post-Review Phase ] LEGEND ORA PI

Illustration of Secondary Findings – Concurrent, Consecutive and Overlapping Submissions Concurrent Consecutive Overlapping

Sarah Faghihi (317) phone (317) fax Faith Pottschmidt (317) phone (317) fax